ROIV
Roivant Sciences Ltd. · Healthcare
Director Daniel Allen Gold sold $49.4M of Roivant Sciences Ltd.
Sold$49,354,076
$34.32Price
1,438,163Shares
−10%Stake
What ROIV did after the filing
- The stock from Wed, Jul 1 open, $35.75
- +1.5%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Aug 13 close.
Traded Fri, Jun 26. Filed Tue, Jun 30, 8:30 PM ET, after the close. Returns use the Jul 1 open and the Aug 13 close. Not investment advice.